Business

Collegium to Participate in Upcoming Investor Conference

STOUGHTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the

articleCollegium Pharmaceutical, Inc.May 20, 20215/company/collegium-pharmaceutical-inc/news/collegium-to-participate-in-upcoming-investor-conference-2021-05-20
Collegium to Participate in Upcoming Investor Conference

About this update from Collegium Pharmaceutical, Inc.

[{"type":"text","content":"STOUGHTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conference: Jefferies Virtual Healthcare Conference Format: Fireside chat Date: Wednesday, June 2, 2021Time: 4:30 PM Eastern Time The presentation will be webcast live and may be accessed from the Investor section of the Company’s website: https://ir.collegiumpharma.com. A replay of the webcast will be available on the Company’s website for approximately 30 days after the event. About Collegium Pharmaceutical, Inc. Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com. Contact: Alex [email protected] \nSource: Collegium Pharmaceutical, Inc.","length":2727,"tagName":"div"}]

More updates from Collegium Pharmaceutical, Inc.